MK6892

MK6892 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 2 (GPR109A). It has been investigated for lowering blood lipid levels and potential applications in the treatment of colon cancer.^[1][2][3][4]

MK6892

Identifiers
IUPAC name 2-[[3-[3-(5-hydroxypyridin-2-yl)-1,2,4-oxadiazol-5-yl]-2,2-dimethylpropanoyl]amino]cyclohexene-1-carboxylic acid
CAS Number	917910-45-3
PubChem CID	135416394
IUPHAR/BPS	5788
ChemSpider	24664360
UNII	PH9ZB6IRW0
ChEMBL	ChEMBL1086657
Chemical and physical data
Formula	C19H22N4O5
Molar mass	386.408 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)(CC1=NC(=NO1)C2=NC=C(C=C2)O)C(=O)NC3=C(CCCC3)C(=O)O
InChI InChI=1S/C19H22N4O5/c1-19(2,18(27)21-13-6-4-3-5-12(13)17(25)26)9-15-22-16(23-28-15)14-8-7-11(24)10-20-14/h7-8,10,24H,3-6,9H2,1-2H3,(H,21,27)(H,25,26) Key:CJHXBFSJXDUJHP-UHFFFAOYSA-N